NOTICE TO HOSPITALS
Cannot obtain FDA-approved drugs?
Outsourcing Facilities are subject to MORE QUALITY STANDARDS than other compounders and supply drugs in shortage.
Hospitals that cannot obtain adequate supplies of FDA-approved drugs and are considering the use of compounded drugs for their hospitalized patients should first contact outsourcing facilities, which are subject to more robust quality standards than state-licensed pharmacies or federal facilities that do not register with FDA as outsourcing facilities.
ABOUT THE OFA
The Outsourcing Facilities Association (OFA) is the trade association representing FDA-registered 503B outsourcing facilities who focus on providing patients and healthcare providers with safe and effective compounded medications. OFA members work with patients, healthcare providers, and facilities on a daily basis to ensure the specific needs, of both providers and patients, for compounded medications are satisfied. OFA will continue to work with industry, governmental agencies, and healthcare providers to educate and advocate for outsourcing facilities and the critical need to ensure that patients and providers have access to the medications they need.
503B POSSIBLE SOURCES OF DRUGS USED FOR HOSPITALIZED PATIENTS WITH COVID-19
(updated daily, last update October 30)
Not every 503B listed below is a member of OFA. If you would like to speak with any of the 503Bs listed below, please reach out directly to the 503B. The information below is directly from the publicly available FDA website and required 6-month product reports published by the FDA. In addition, 503Bs who are developing formulations, which may be released soon, may also have a product listed. If you are associated with the 503B and want to update this information, please reach out to OFA at any time to update this information.
The products listed below are related to FDA's List of Drugs Used for Hospitalized Patients with COVID-19 in FDA's Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency. OFA makes NO representation to the quantity or nature of any product listed below. Please reach out to the company directly for additional information. OFA has no pricing data for any product listed below and all questions should be directed to the 503B directly.
Many of these 503Bs have additional products available that are listed on FDA's Drug Shortage List. Please inquire with 503Bs directly for a full product catalog.
FDA's List of Drugs Used for Hospitalized Patients
with COVID-19
FDA Drug Shortage
Dexmedetomidine hydrochloride
Epinephrine - FDA Drug Shortage
Midazolam hydrochloride
Norepinephrine bitartrate
Rocuronium bromide
Vancomycin hydrochloride
Dexmedetomidine hydrochloride
Dextrose 50% - FDA Drug Shortage
Doxycyline hyclate - FDA Drug Shortage
Lidocaine hydrochloride - FDA Drug Shortage
Sodium chloride 0.9% - FDA Drug Shortage
Sodium chloride 23.4% - FDA Drug Shortage
Fentanyl citrate
Hydromorphone hydrochloride
Morphine sulfate
Epinephrine - FDA Drug Shortage
Fentanyl citrate
Hydromorphone hydrochloride
Midazolam hydrochloride
Morphine sulfate
Norepinephrine bitartrate
Rocuronium bromide
Vancomycin hydrochloride
Vecuronium bromide
Atropine sulfate - FDA Drug Shortage
Bupivacaine hydrochloride - FDA Drug Shortage
Cisatracurium besylate
Dexamethasone sodium phosphate
Epinephrine - FDA Drug Shortage
Fentanyl citrate
Hydromorphone hydrochloride
Ketamine hydrochloride
Midazolam hydrochloride
Methadone hydrochloride - FDA Drug Shortage
Morphine sulfate
Rocuronium bromide
Ropivacaine hydrochloride - FDA Drug Shortage
Triamcinolone acetonide - FDA Drug Shortage
​
Atropine sulfate - FDA Drug Shortage
Bupivacaine hydrochloride - FDA Drug Shortage
Dexamethasone sodium phosphate
Dexmedetomidine hydrochloride
Epinephrine - FDA Drug Shortage
Fentanyl citrate
Hydromorphone hydrochloride
Ketamine hydrochloride
Lidocaine hydrochloride - FDA Drug Shortage
Midazolam hydrochloride
Morphine sulfate
Rocuronium bromide
Ropivacaine hydrochloride - FDA Drug Shortage
Sodium bicarbonate - FDA Drug Shortage
Bupivacaine hydrochloride - FDA Drug Shortage
Ketamine hydrochloride
Ketorolac tromethamine - FDA Drug Shortage
Lidocaine hydrochloride - FDA Drug Shortage
Midazolam hydrochloride
Ondansetron hydrochloride - FDA Drug Shortage
Ropivacaine hydrochloride - FDA Drug Shortage
Ketamine hydrochloride
Labetalol hydrochloride - FDA Drug Shortage
​Lidocaine hydrochloride - FDA Drug Shortage
Midazolam hydrochloride
Morphine sulfate
Rocuronium bromide
Sodium Bicarbonate - FDA Drug Shortage
Fentanyl citrate
Ketamine hydrochloride
Hydromorphone hydrochloride
Labetalol hydrochloride - FDA Drug Shortage
Lidocaine hydrochloride - FDA Drug Shortage
Midazolam hydrochloride
Morphine sulfate
Ropivacaine hydrochloride - FDA Drug Shortage
SSM HEALTH CARE CORPORATION
Fentanyl citrate
Hydromorphone hydrochloride
Norepinephrine bitartrate
Fentanyl citrate
Hydromorphone hydrochloride
Ketamine hydrochloride
Midazolam hydrochloride
​Morphine sulfate
Norepinephrine bitartrate
Rocuronium bromide
Vancomycin hydrochloride
​
Dexamethasone sodium phosphate
Epinephrine - FDA Drug Shortage
Fentanyl citrate
Hydromorphone hydrochloride
Ketamine hydrochloride
Midazolam hydrochloride
Morphine sulfate
Norepinephrine bitartrate
Rocuronium bromide
Vancomycin hydrochloride
Epinephrine - FDA Drug Shortage
Fentanyl citrate
Hydromorphone hydrochloride
Ketamine hydrochloride
Lorazepam
Midazolam hydrochloride
Morphine sulfate
Norepinephrine bitartrate
Rocuronium bromide
CONTACT US
Interested in becoming a member or simply have questions about the Outsourcing Facilities Association or 503B industry? We’d love to hear from you, so don’t hesitate in reaching out today.